Business & Finance

Anika Therapeutics reports net income of $0.12 per share

Published in Healthcare Finance, Tax and Law Weekly, November 22nd, 2006

Anika Therapeutics, Inc., (ANIK) reported financial results for the third quarter and 9 months ended September 30, 2006.

Anika reported product revenue of $5,494,000 for the third quarter of 2006 compared with $5,999,000 in the same period last year. Product revenue for the first 9 months of 2006 was $18,876,000 compared with $15,760,000 in the 9 month period a year ago. Product revenue for both years was impacted by several factors: Reduced sales to Turkey in the third quarter of 2006 due to a change in the government's reimbursement policy for over 100 drugs including Orthovisc and its competing products, which was more than offset by increased revenue in the U.S....

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly

Source: Healthcare Finance, Tax and Law Weekly (2006-11-22)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry